In a regulatory filing, Cadila said in its opinion this particular matter is not likely to have any material impact on the operations and financials of the company.
Zydus Pharmaceuticals Inc among cos facing lawsuit by US states: Cadila
More from Industry NewsMore posts in Industry News »
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
- India initiates antidumping probe on certain type of steel from Brazil, China, Germany
- BDR Pharma receives DGCI nod for its generic drug BIAPENEM
- AstraZeneca invests in Imperial’s self-amplifying RNA technology with eye on future drugs